Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Trejo Solís, Cristina ^a   Pedraza Chaverrí, Jose ^b   Torres Ramos, Mónica ^b   Jiménez Farfán, Dolores ^b   Cruz Salgado, Arturo ^b   Serrano García, Norma ^b   Osorio Rico, Laura ^a   Sotelo, Julio ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BETA CATENIN; CYCLIN DEPENDENT KINASE; EPIDERMAL GROWTH FACTOR; GENISTEIN; INHIBITOR OF APOPTOSIS PROTEIN; LYCOPENE; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; VASCULOTROPIN; WNT PROTEIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; CANCER RADIOTHERAPY; CARCINOGENESIS; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE REGULATION; CLINICAL PRACTICE; COLON CANCER; DRUG POTENTIATION; FRUIT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIVER CANCER; LUNG CANCER; METASTASIS; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SIGNAL TRANSDUCTION; TOMATO; TRANSCRIPTION INITIATION; VEGETABLE; WNT SIGNALING PATHWAY;

EID: 84881531024     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/705121     Document Type: Review

References (124)

1. Pitot H. C., The molecular biology of carcinogenesis. Cancer 1993 72 supplement 3 962 970 2-s2.0-0027274815 (Pubitemid 23218011)
2. Mukhtar H., Ahmad N., Cancer chemoprevention: future holds in multiple agents. Toxicology and Applied Pharmacology 1999 158 3 207 210 2-s2.0-0033179705 10.1006/taap.1999.8721 (Pubitemid 29382938)
3. Manson M. M., Cancer prevention-the potential for diet to modulate molecular signalling. Trends in Molecular Medicine 2003 9 1 11 18 2-s2.0-0037248328 10.1016/S1471-4914(02)00002-3 (Pubitemid 36139250)
4. Ahmad N., Katiyard S. K., Mukhtar H., loannides C., Cancer chemoprevention by tea polyphenols. Nutrition and Chemical Toxicity 1998 Chichester, UK John Wiley & Sons 301 344
5. Surh Y.-J., Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 2003 3 10 768 780 2-s2.0-0142166328 (Pubitemid 37328815)
6. Challa A., Ahmad N., Mukhtar H., Cancer prevention through sensible nutrition (commentary). International Journal of Oncology 1997 11 6 1387 1392 2-s2.0-0030774098 (Pubitemid 27502099)
7. Sporn M. B., Liby K. T., Cancer chemoprevention: scientific promise, clinical uncertainty. Nature Clinical Practice Oncology 2005 2 10 518 525 2-s2.0-27644477094 10.1038/ncponc0319 (Pubitemid 41553936)
8. Chen J., Pu Z., Xiao Y., Lycopene synthesis via tri-cistronic expression of LeGGPS2, LePSY1 and crtI in Escherichia coli. Sheng Wu Gong Cheng Xue Bao 2012 28 7 823 833
9. Olson J. A., Krinsky N. I., Introduction: the colorful, fascinating world of the carotenoids: important physiologic modulators. The Journal of the Federation of American Societies for Experimental Biology 1995 9 15 1547 1550 2-s2.0-0029186920
10. Clinton S. K., Lycopene: chemistry, biology, and implications for human health and disease. Nutrition Reviews 1998 56 2, part 1 35 51 2-s2.0-0031889382 (Pubitemid 28132684)
11. Tonucci L. H., Holden J. M., Beecher G. R., Khachik F., Davis C. S., Mulokozi G., Carotenoid content of thermally processed tomato-based food products. Journal of Agricultural and Food Chemistry 1995 43 3 579 586 2-s2.0-0000653440
12. Mangels A. R., Holden J. M., Beecher G. R., Forman M. R., Lanza E., Carotenoid content of fruits and vegetables: an evaluation of analytic data. Journal of the American Dietetic Association 1993 93 3 284 296 2-s2.0-0027523227 10.1016/0002-8223(93)91553-3 (Pubitemid 23070877)
13. Giovannucci E., Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. Journal of the National Cancer Institute 1999 91 4 317 331 2-s2.0-0033577044 (Pubitemid 29102331)
14. Dorgan J. F., Sowell A., Swanson C. A., Potischman N., Miller R., Schussler N., Stephenson H. E. Jr., Relationships of serum carotenoids, retinol, α -tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes and Control 1998 9 1 89 97 2-s2.0-0031964487 10.1023/A:1008857521992 (Pubitemid 28048664)
15. Kirsh V. A., Mayne S. T., Peters U., Chatterjee N., Leitzmann M. F., Dixon L. B., Urban D. A., Crawford E. D., Hayes R. B., A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention 2006 15 1 92 98 2-s2.0-33645453765 10.1158/1055-9965.EPI-05-0563
16. Hausladen A., Stamler J. S., Nitrosative stress. Methods in Enzymology 1999 300 389 395 2-s2.0-0031797256 10.1016/S0076-6879(99)00143-3 (Pubitemid 28500613)
17. Halliwell B., Aruoma O. I., DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. Federation of European Biochemical Societies Letter 1991 281 1-2 9 19 2-s2.0-0025972738 10.1016/0014-5793(91)80347-6
18. Ames B. N., Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983 221 4617 1256 1264 2-s2.0-0020508747
19. Krinsky N. I., Mechanism of action of biological antioxidants. Proceedings of the Society for Experimental Biology and Medicine 1992 200 2 248 254 2-s2.0-0026764691
20. di Mascio P., Kaiser S., Sies H., Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Archives of Biochemistry and Biophysics 1989 274 2 532 538 2-s2.0-0024464691 (Pubitemid 19261144)
21. Krinsky N. I., The antioxidant and biological properties of the carotenoids. Annals of the New York Academy of Sciences 1998 854 443 447 2-s2.0-0032442246 10.1111/j.1749-6632.1998.tb09923.x (Pubitemid 29022823)
22. Bast A., Haenen G. R. M. M., van den Berg R., van den Berg H., Antioxidant effects of carotenoids. International Journal for Vitamin and Nutrition Research 1998 68 6 399 403 2-s2.0-0031773970
23. Matos H. R., di Mascio P., Medeiros M. H. G., Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture. Archives of Biochemistry and Biophysics 2000 383 1 56 59 2-s2.0-0034326266 10.1006/abbi.2000.2035
24. Rizwan M., Rodriguez-Blanco I., Harbottle A., Birch-Machin M. A., Watson R. E. B., Rhodes L. E., Tomato paste rich in lycopene protects against cutaneous photodamage in humans in vivo: a randomized controlled trial. British Journal of Dermatology 2011 164 1 154 162 2-s2.0-78650478990 10.1111/j.1365-2133.2010. 10057.x
25. Muzandu K., Ishizuka M., Sakamoto K. Q., Shaban Z., El Bohi K., Kazusaka A., Fujita S., Effect of lycopene and β -carotene on peroxynitrite-mediated cellular modifications. Toxicology and Applied Pharmacology 2006 215 3 330 340 2-s2.0-33748058810 10.1016/j.taap.2006.03.006 (Pubitemid 44301346)
26. Liu A., Pajkovic N., Pang Y., Zhu D., Calamini B., Mesacar A. L., van Breemen R. B., Absorption and subcellular localization of lycopene in human prostate cancer cells. Molecular Cancer Therapeutics 2006 5 11 2879 2885 2-s2.0-33845230150 10.1158/1535-7163.MCT-06-0373 (Pubitemid 44849015)
27. Ben-Dor A., Steiner M., Gheber L., Danilenko M., Dubi N., Linnewiel K., Zick A., Sharoni Y., Levy J., Carotenoids activate the antioxidant response element transcription system. Molecular Cancer Therapeutics 2005 4 1 177 186 2-s2.0-13944262936 (Pubitemid 40268075)
28. Velmurugan B., Bhuvaneswari V., Nagini S., Antiperoxidative effects of lycopene during N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis. Fitoterapia 2002 73 7-8 604 611 2-s2.0-0036916637 10.1016/S0367-326X(02)00216-2 (Pubitemid 35477756)
29. Bhuvaneswari V., Velmurugan B., Balasenthil S., Ramachandran C. R., Nagini S., Chemopreventive efficacy of lycopene on 7,12-dimethylbenz[a] anthracene-induced hamster buccal pouch carcinogenesis. Fitoterapia 2001 72 8 865 874 2-s2.0-0035209696 10.1016/S0367-326X(01)00321-5 (Pubitemid 33122194)
30. Cullinan S. B., Gordan J. D., Jin J., Harper J. W., Diehl J. A., The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Molecular and Cellular Biology 2004 24 19 8477 8486 2-s2.0-4544294365 10.1128/MCB.24.19.8477-8486.2004 (Pubitemid 39245070)
31. Kensler T. W., Wakabayashi N., Biswal S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual Review of Pharmacology and Toxicology 2007 47 89 116 2-s2.0-33847050801 10.1146/annurev.pharmtox.46.120604.141046
32. Lian F., Wang X.-D., Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. International Journal of Cancer 2008 123 6 1262 1268 2-s2.0-49749133236 10.1002/ijc.23696
33. Itoh K., Tong K. I., Yamamoto M., Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radical Biology and Medicine 2004 36 10 1208 1213 2-s2.0-1942455887 10.1016/j.freeradbiomed.2004.02.075 (Pubitemid 38526314)
34. Zhang H., Forman H. J., Acrolein induces heme oxygenase-1 through PKC- δ and PI3K in human bronchial epithelial cells. American Journal of Respiratory Cell and Molecular Biology 2008 38 4 483 490 2-s2.0-41449112375 10.1165/rcmb.2007-0260OC (Pubitemid 351758695)
35. Papaiahgari S., Zhang Q., Kleeberger S. R., Cho H.-Y., Reddy S. P., Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-P13K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells. Antioxidants and Redox Signaling 2006 8 1-2 43 52 2-s2.0-33644649422 10.1089/ars.2006.8.43 (Pubitemid 43324529)
36. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., Walter P., Molecular Biology of the Cell 2002 4th New York, NY, USA Garland Science
37. Folli F., Bonfanti L., Renard E., Kahn C. R., Merighi A., Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system. Journal of Neuroscience 1994 14 11, part 1 6412 6422 2-s2.0-0028029856 (Pubitemid 24333063)
38. Jones J. I., Clemmons D. R., Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 1995 16 1 3 34 2-s2.0-0028958031
39. DiGiovanni J., Kiguchi K., Frijhoff A., Wilker E., Bol D. K., Beltrán L., Moats S., Ramirez A., Jorcano J., Conti C., Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 2000 97 7 3455 3460 2-s2.0-12944335316 10.1073/pnas.97.7.3455 (Pubitemid 30183324)
40. Giovannucci E., Insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) and risk of cancer. Hormone Research 1999 51 34 41
41. Levy J., Bosin E., Feldman B., Giat Y., Miinster A., Danilenko M., Sharoni Y., Lycopene is a more potent inhibitor of human cancer cell proliferation than either α -carotene or β -carotene. Nutrition and Cancer 1995 24 3 257 266 2-s2.0-0028863013
42. Vrieling A., Voskuil D. W., Bonfrer J. M., Korse C. M., Van Doorn J., Cats A., Depla A. C., Timmer R., Witteman B. J., Van Leeuwen F. E., Van't Veer L. J., Rookus M. A., Kampman E., Lycopene supplementation elevates circulating insulin-like growth factor- binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer. The American Journal of Clinical Nutrition 2007 86 5 1456 1462 2-s2.0-36249009704 (Pubitemid 350126251)
43. Liu C., Lian F., Smith D. E., Russell R. M., Wang X.-D., Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Research 2003 63 12 3138 3144 2-s2.0-0038407714 (Pubitemid 36735865)
44. Tang Y., Parmakhtiar B., Simoneau A. R., Xie J., Fruehauf J., Lilly M., Zi X., Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels. Neoplasia 2011 13 2 108 119 2-s2.0-79951471546 10.1593/neo.101092
45. Heldin C.-H., Eriksson U., Östman A., New members of the platelet-derived growth factor family of mitogens. Archives of Biochemistry and Biophysics 2002 398 2 284 290 2-s2.0-0037085234 10.1006/abbi.2001.2707 (Pubitemid 34848597)
46. Hoch R. V., Soriano P., Roles of PDGF in animal development. Development 2003 130 20 4769 4784 2-s2.0-0142243109 10.1242/dev.00721 (Pubitemid 37321862)
47. Lo H.-M., Hung C.-F., Tseng Y.-L., Chen B.-H., Jian J.-S., Wu W.-B., Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells. Biochemical Pharmacology 2007 74 1 54 63 2-s2.0-34249110578 10.1016/j.bcp.2007.03.017 (Pubitemid 46802489)
48. Li W., Fan J., Chen M., Guan S., Sawcer D., Bokoch G. M., Woodley D. T., Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB. Molecular Biology of the Cell 2004 15 1 294 309 2-s2.0-0347990559 10.1091/mbc.E03-05-0352 (Pubitemid 38044964)
49. Chen C.-P., Hung C.-F., Lee S.-C., Lo H.-M., Wu P.-H., Wu W.-B., Lycopene binding compromised PDGF-AA/-AB signaling and migration in smooth muscle cells and fibroblasts: prediction of the possible lycopene binding site within PDGF. Naunyn-Schmiedeberg's Archives of Pharmacology 2010 381 5 401 414 2-s2.0-77953231676 10.1007/s00210-010-0501-1
50. Chiang H.-S., Wu W.-B., Fang J.-Y., Chen D.-F., Chen B.-H., Huang C.-C., Chen Y.-T., Hung C.-F., Lycopene inhibits PDGF-BB-induced signaling and migration in human dermal fibroblasts through interaction with PDGF-BB. Life Sciences 2007 81 21-22 1509 1517 2-s2.0-36048994255 10.1016/j.lfs.2007.09.018 (Pubitemid 350081040)
51. Shibuya M., Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Structure and Function 2001 26 1 25 35 2-s2.0-0035003384 10.1247/csf.26.25 (Pubitemid 32421949)
52. Risau W., Mechanisms of angiogenesis. Nature 1997 386 6626 671 674 2-s2.0-0030952289 (Pubitemid 27193480)
53. Şahin M., Şahin E., Gümüşlü S., Effects of lycopene and apigenin on human umbilical vein endothelial cells in vitro under angiogenic stimulation. Acta Histochemica 2012 114 2 94 100 10.1016/j.acthis.2011.03.004
54. Yang C.-M., Yen Y.-T., Huang C.-S., Hu M.-L., Growth inhibitory efficacy of lycopene and β -carotene against androgen-independent prostate tumor cells xenografted in nude mice. Molecular Nutrition & Food Research 2011 55 4 606 612 2-s2.0-79953309675 10.1002/mnfr.201000308
55. Chen M. L., Lin Y. H., Yang C. M., Hu M. L., Lycopene inhibis angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-AKT and ERK/p38 signaling pathways. Molecular Nutrition & Food Research 2012 56 5 889 899 10.1002/mnfr.201100683
56. Murray A. W., Recycling the cell cycle: cyclins revisited. Cell 2004 116 2 221 234 2-s2.0-0842324788 10.1016/S0092-8674(03)01080-8 (Pubitemid 38167314)
57. Alao J. P., The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Molecular Cancer 2007 6, article 24 2-s2.0-34247149015 10.1186/1476-4598-6-24 (Pubitemid 46585441)
58. Sherr C. J., The pezcoller lecture: cancer cell cycles revisited. Cancer Research 2000 60 14 3689 3695 2-s2.0-0034660892 (Pubitemid 32204552)
59. Park Y. O., Hwang E.-S., Moon T. W., The effect of lycopene on cell growth and oxidative DNA damage of Hep3B human hepatoma cells. BioFactors 2005 23 3 129 139 2-s2.0-30644470449 10.1002/biof.5520230302 (Pubitemid 43086340)
60. Nahum A., Hirsch K., Danilenko M., Watts C. K. W., Prall O. W. J., Levy J., Sharoni Y., Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27 Kip1 in the cyclin E-cdk2 complexes. Oncogene 2001 20 26 3428 3436 2-s2.0-0035821778 10.1038/sj.onc.1204452 (Pubitemid 32588991)
61. Nahum A., Zeller L., Danilenko M., Prall O. W. J., Watts C. K. W., Sutherland R. L., Levy J., Sharoni Y., Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. European Journal of Nutrition 2006 45 5 275 282 2-s2.0-33746773068 10.1007/s00394-006-0595-x (Pubitemid 44167661)
62. Karas M., Amir H., Fishman D., Danilenko M., Segal S., Nahum A., Koifmann A., Giat Y., Levy J., Sharoni Y., Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutrition and Cancer 2000 36 1 101 111 2-s2.0-17144452288 (Pubitemid 30317841)
63. Palozza P., Colangelo M., Simone R., Catalano A., Boninsegna A., Lanza P., Monego G., Ranelletti F. O., Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. Carcinogenesis 2010 31 10 1813 1821 2-s2.0-77957757788 10.1093/carcin/bgq157
64. Chang C.-C., Chen W.-C., Ho T.-F., Wu H.-S., Wei Y.-H., Development of natural anti-tumor drugs by microorganisms. Journal of Bioscience and Bioengineering 2011 111 5 501 511 2-s2.0-79954959102 10.1016/j.jbiosc.2010.12. 026
65. Wang Z., Fukushima H., Inuzuka H., Skp2 is a promising therapeutic target in breast cancer. Frontiers in Oncology 2012 1 57, pii 18702 10.3389/fonc.2011.00057
66. Lian F., Smith D. E., Ernst H., Russell R. M., Wang X.-D., Apo-10′-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 2007 28 7 1567 1574 2-s2.0-34547800757 10.1093/carcin/bgm076 (Pubitemid 47241807)
67. Ford N. A., Elsen A. C., Zuniga K., Lindshield B. L., Erdman J. W. Jr., Lycopene and apo-12′-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells. Nutrition and Cancer 2011 63 2 256 263 2-s2.0-79951864386 10.1080/01635581.2011.523494
68. Green D. R., Kroemer G., The pathophysiology of mitochondrial cell death. Science 2004 305 5684 626 629 2-s2.0-3442886811 10.1126/science.1099320 (Pubitemid 39006738)
69. Sandu C., Gavathiotis E., Huang T., Wegorzewska I., Werner M. H., A mechanism for death receptor discrimination by death adaptors. The Journal of Biological Chemistry 2005 280 36 31974 31980 2-s2.0-24744454606 10.1074/jbc.M506938200 (Pubitemid 41291948)
70. Lüschen S., Falk M., Scherer G., Ussat S., Paulsen M., Adam-Klages S., The Fas-associated death domain protein/caspase-8/c-FLIP signaling pathway is involved in TNF-induced activation of ERK. Experimental Cell Research 2005 310 1 33 42 2-s2.0-25844490942 10.1016/j.yexcr.2005.07.022 (Pubitemid 41393685)
71. MacFarlane M., Williams A. C., Apoptosis and disease: a life or death decision. European Molecular Biology Organitation Reports 2004 5 7 674 678 2-s2.0-4444324090 10.1038/sj.embor.7400191 (Pubitemid 39173000)
72. Verhagen A. M., Vaux D. L., Cell death regulation by the mammalian IAP antagonist Diablo/Smac. Apoptosis 2002 7 2 163 166 2-s2.0-0036204018 10.1023/A:1014318615955 (Pubitemid 34273131)
73. Haupt S., Berger M., Goldberg Z., Haupt Y., Apoptosis-the p53 network. Journal of Cell Science 2003 116, part 20 4077 4085 2-s2.0-0242319666 10.1242/jcs.00739 (Pubitemid 37337082)
74. Tang F.-Y., Cho H.-J., Pai M.-H., Chen Y.-H., Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells. The Journal of Nutritional Biochemistry 2009 20 6 426 434 2-s2.0-67349125876 10.1016/j.jnutbio.2008.05.001
75. Velmurugan B., Mani A., Nagini S., Combination of S-allylcysteine and lycopene induces apoptosis by modulating Bcl-2, Bax, Bim and caspases during experimental gastric carcinogenesis. European Journal of Cancer Prevention 2005 14 4 387 393 2-s2.0-23344447085 10.1097/00008469-200508000-00012 (Pubitemid 41104948)
76. Zhang H., Kotake-Nara E., Ono H., Nagao A., A novel cleavage product formed by autoxidation of lycopene induces apoptosis in HL-60 cells. Free Radical Biology and Medicine 2003 35 12 1653 1663 2-s2.0-0346366738 10.1016/j.freeradbiomed.2003.09.019 (Pubitemid 37532916)
77. Wakshlag J. J., Balkman C. E., Effects of lycopene on proliferation and death of canine osteosarcoma cells. American Journal of Veterinary Research 2010 71 11 1362 1370 2-s2.0-78149379720 10.2460/ajvr.71.11.1362
78. Hantz H. L., Young L. F., Martin K. R., Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Experimental Biology and Medicine 2005 230 3 171 179 2-s2.0-14344259481 (Pubitemid 40293690)
79. Sahin K., Tuzcu M., Sahin N., Akdemir F., Ozercan I., Bayraktar S., Kucuk O., Inhibitory effects of combination of lycopene and genistein on 7,12- Dimethyl benz(a)anthracene-induced breast cancer in rats. Nutrition and Cancer 2011 63 8 1279 1286 2-s2.0-84857134219 10.1080/01635581.2011.606955
80. Wang A., Zhang L., Effect of lycopene on proliferation and cell cycle of hormone refractory prostate cancer PC-3 cell line. Wei Sheng Yan Jiu 2007 36 5 575 578 2-s2.0-76449118095
81. Palozza P., Serini S., Boninsegna A., Bellovino D., Lucarini M., Monastra G., Gaetani S., The growth-inhibitory effects of tomatoes digested in vitro in colon adenocarcinoma cells occur through down regulation of cyclin D1, Bcl-2 and Bcl-xL. British Journal of Nutrition 2007 98 4 789 795 2-s2.0-34748891785 10.1017/S0007114507746883 (Pubitemid 47487946)
82. Palozza P., Sheriff A., Serini S., Boninsegna A., Maggiano N., Ranelletti F. O., Calviello G., Cittadini A., Lycopene induces apoptosis in immortalized fibroblasts exposed to tobacco smoke condensate through arresting cell cycle and down-regulating cyclin D1, pAKT and pBad. Apoptosis 2005 10 6 1445 1456 2-s2.0-30944458833 10.1007/s10495-005-1393-2 (Pubitemid 43117688)
83. Tang Y., Parmakhtiar B., Simoneau A. R., Xie J., Fruehauf J., Lilly M., Zi X., Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels. Neoplasia 2011 13 2 108 119 2-s2.0-79951471546 10.1593/neo.101092
84. Hunter K. W., Crawford N. P. S., Alsarraj J., Mechanisms of metastasis. Breast Cancer Research 2008 10, supplement 1, article S2 2-s2.0-58249092965 10.1186/bcr1988
85. Bacac M., Stamenkovic I., Metastatic cancer cell. Annual Review of Pathology 2008 3 221 247 2-s2.0-41749100830 10.1146/annurev.pathmechdis.3. 121806.151523 (Pubitemid 351488281)
86. Lin S.-Y., Xia W., Wang J. C., Kwong K. Y., Spohn B., Wen Y., Pestell R. G., Hung M.-C., β -catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proceedings of the National Academy of Sciences of the United States of America 2000 97 8 4262 4266 2-s2.0-0034636153 10.1073/pnas.060025397 (Pubitemid 30226121)
87. Nelson W. J., Nusse R., Convergence of Wnt, β -catenin, and cadherin pathways. Science 2004 303 5663 1483 1487 2-s2.0-1542347695 10.1126/science.1094291 (Pubitemid 38314410)
88. Kim H.-S., Skurk C., Thomas S. R., Bialik A., Suhara T., Kureishi Y., Birnbaum M., Keaney J. F. Jr., Kenneth Walsh S., Regulation of angiogenesis by glycogen synthase kinase-3 β The Journal of Biological Chemistry 2002 277 44 41888 41896 2-s2.0-0036829025 10.1074/jbc.M206657200 (Pubitemid 35257501)
89. Tetsu O., McCormick F., β -catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999 398 6726 422 426 2-s2.0-0033119801 10.1038/18884 (Pubitemid 29180374)
90. Gradl D., Kühl M., Wedlich D., The Wnt/Wg signal transducer β -catenin controls fibronectin expression. Molecular and Cellular Biology 1999 19 8 5576 5587 2-s2.0-0344171934 (Pubitemid 29339915)
91. Simone R. E., Russo M., Catalano A., Monego G., Froehlich K., Boehm V., Palozza P., Lycopene inhibits NF-KB-Mediated IL-8 expression and changes redox and PPAR γ signalling in cigarette smoke-stimulated macrophages. PLoS ONE 2011 6 5, article e19652 2-s2.0-79956282901 10.1371/journal.pone.0019652
92. Feng D., Ling W.-H., Duan R.-D., Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF- B in macrophages. Inflammation Research 2010 59 2 115 121 2-s2.0-77949270779 10.1007/s00011-009-0077-8
93. Rafi M. M., Yadav P. N., Reyes M., Lycopene inhibits LPS-induced proinflammatory mediator inducible nitric oxide synthase in mouse macrophage cells. Journal of Food Science 2007 72 1 S069 S074 2-s2.0-38349085887 10.1111/j.1750-3841.2006.00219.x
94. Tang F.-Y., Pai M.-H., Wang X.-D., Consumption of lycopene inhibits the growth and progression of colon cancer in a mouse xenograft model. Journal of Agricultural and Food Chemistry 2011 59 16 9011 9021 2-s2.0-80051743214 10.1021/jf2017644
95. Lin M.-C., Wang F.-Y., Kuo Y.-H., Tang F.-Y., Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells. Journal of Agricultural and Food Chemistry 2011 59 20 11304 11318 2-s2.0-80054995016 10.1021/jf202433f
96. Tang F.-Y., Shih C.-J., Cheng L.-H., Ho H.-J., Chen H.-J., Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway. Molecular Nutrition & Food Research 2008 52 6 646 654 2-s2.0-49649112171 10.1002/mnfr.200700272
97. Hwang E.-S., Lee H. J., Inhibitory effects of lycopene on the adhesion, invasion, and migration of SK-Hep1 human hepatoma cells. Experimental Biology and Medicine 2006 231 3 322 327 2-s2.0-33644671562 (Pubitemid 43334319)
98. Huang C.-S., Shih M.-K., Chuang C.-H., Hu M.-L., Lycopene inhibits cell migration and invasion and upregulates Nm23-H1 in a highly invasive hepatocarcinoma, SK-Hep-1 cells. Journal of Nutrition 2005 135 9 2119 2123 2-s2.0-24744436403 (Pubitemid 41298375)
99. Huang C.-S., Liao J.-W., Hu M.-L., Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. Journal of Nutrition 2008 138 3 538 543 2-s2.0-40449110427 (Pubitemid 351355254)
100. Yang C.-M., Hu T.-Y., Hu M.-L., Antimetastatic effects and mechanisms of apo-8′-lycopenal, an enzymatic metabolite of lycopene, against human hepatocellular carcinoma SK-Hep-1 cells. Nutrition and Cancer 2012 64 2 274 285 10.1080/01635581.2012.643273
101. Huang C.-S., Fan Y.-E., Lin C.-Y., Hu M.-L., Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. The Journal of Nutritional Biochemistry 2007 18 7 449 456 2-s2.0-34249913180 10.1016/j.jnutbio.2006.08.007 (Pubitemid 46874919)
102. Mira E., Mañes S., Lacalle R. A., Márquez G., Martínez A. C., Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9. Endocrinology 1999 140 4 1657 1664 2-s2.0-0033053127 (Pubitemid 29149234)
103. Liu X., Allen J. D., Arnold J. T., Blackman M. R., Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells. Carcinogenesis 2008 29 4 816 823 2-s2.0-41849127826 10.1093/carcin/bgn011 (Pubitemid 351494170)
104. Altavilla D., Bitto A., Polito F., Irrera N., Marini H., Arena S., Favilla V., Squadrito F., Morgia G., Minutoli L., The combination of serenoa repens, selenium and lycopene is more effective than serenoa repens alone to prevent hormone dependent prostatic growth. Journal of Urology 2011 186 4 1524 1529 2-s2.0-80052729401 10.1016/j.juro.2011.05.049
105. Molnár J., Gyémánt N., Mucsi I., Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids. In Vivo 2004 18 2 237 244 (Pubitemid 38489008)
106. Warrell R. P. Jr., Frankel S. R., Miller W. H. Jr., Scheinberg D. A., Itri L. M., Hittelman W. N., Vyas R., Andreeff M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M. S., Dmitrovsky E., Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). The New England Journal of Medicine 1991 324 20 1385 1393 2-s2.0-0025882306
107. Christakos S., Raval-Pandya M., Wernyj R. P., Yang W., Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3. The Biochemical Journal 1996 316, part 2 361 371 2-s2.0-0030013405 (Pubitemid 26182127)
108. Amir H., Karas M., Giat J., Danilenko M., Levy R., Yermiahu T., Levy J., Sharoni Y., Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutrition and Cancer 1999 33 1 105 112 2-s2.0-0033008852 (Pubitemid 29196131)
109. Tang F.-Y., Pai M.-H., Kuo Y.-H., Wang X.-D., Concomitant consumption of lycopene and fish oil inhibits tumor growth and progression in a mouse xenograft model of colon cancer. Molecular Nutrition & Food Research 2012 56 10 1520 1531 10.1002/mnfr.201200098
110. Velmurugan B., Bhuvaneswari V., Burra U. K., Nagini S., Prevention of N-methyl-N′-nitro-N-nitrosoguanidine and saturated sodium chloride-induced gastric carcinogenesis in Wistar rats by lycopene. European Journal of Cancer Prevention 2002 11 1 19 26 2-s2.0-0036122761 10.1097/00008469-200202000-00004 (Pubitemid 34233073)
111. Al-Malki A. L., Moselhy S. S., Refai M. Y., Synergistic effect of lycopene and tocopherol against oxidative stress and mammary tumorigenesis induced by 7,12-dimethyl[a]benzanthracene in female rats. Toxicology and Industrial Health 2012 28 6 542 548 10.1177/0748233711416948
112. Moselhy S. S., Al Mslmani M. A. B., Chemopreventive effect of lycopene alone or with melatonin against the genesis of oxidative stress and mammary tumors induced by 7,12 dimethyl(a)benzanthracene in sprague dawely female rats. Molecular and Cellular Biochemistry 2008 319 1-2 175 180 2-s2.0-55649119104 10.1007/s11010-008-9890-6
113. Siler U., Barella L., Spitzer V., Schnorr J., Lein M., Goralczyk R., Wertz K., Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB Journal 2004 18 9 1019 1021 2-s2.0-6944226818 10.1096/fj.03-1116fje (Pubitemid 39561511)
114. Dogukan A., Tuzcu M., Agca C. A., Gencoglu H., Sahin N., Onderci M., Ozercan I. H., Ilhan N., Kucuk O., Sahin K., A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression. Nutrition and Cancer 2011 63 3 427 434 2-s2.0-79957560881 10.1080/01635581.2011.535958
115. Preet R., Mohapatra P., Das D., Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC. Carcinogenesis 2013 34 2 277 286 10.1093/carcin/bgs351
116. Yang C.-M., Lu Y.-L., Chen H.-Y., Hu M.-L., Lycopene and the LXR α agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPAR γ -LXR α -ABCA1 pathway. The Journal of Nutritional Biochemistry 2012 23 9 1155 1162 2-s2.0-82255193387 10.1016/j.jnutbio.2011.06.009
117. Palozza P., Catalano A., Simone R. E., Mele M. C., Cittadini A., Effect of lycopene and tomato products on cholesterol metabolism. Annals of Nutrition & Metabolism 2012 61 2 126 134 10.1159/000342077
118. Yang C.-M., Lu I.-H., Chen H.-Y., Hu M.-L., Lycopene inhibits the proliferation of androgen-dependent human prostate tumor cells through activation of PPAR γ -LXR α -ABCA1 pathway. The Journal of Nutritional Biochemistry 2012 23 1 8 17 2-s2.0-83355172499 10.1016/j.jnutbio. 2010.10.006
119. Smith B., Land H., Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Reports 2012 2 3 580 590
120. Andic F., Garipagaoglu M., Yurdakonar E., Tuncel N., Kucuk O., Lycopene in the prevention of gastrointestinal toxicity of radiotherapy. Nutrition and Cancer 2009 61 6 784 788 2-s2.0-77952486015 10.1080/01635580903285171
121. Srinivasan M., Devipriya N., Kalpana K. B., Menon V. P., Lycopene: an antioxidant and radioprotector against γ -radiation-induced cellular damages in cultured human lymphocytes. Toxicology 2009 262 1 43 49 2-s2.0-67649338399 10.1016/j.tox.2009.05.004
122. Fazekas Z., Gao D., Saladi R. N., Lu Y., Lebwohl M., Wei H., Protective effects of lycopene against ultraviolet B-induced photodamage. Nutrition and Cancer 2003 47 2 181 187 2-s2.0-2342507131 (Pubitemid 38590891)
123. Camacho-Alonso F., López-Jornet P., Tudela-Mulero M., Synergic effect of curcumin or lycopene with irradiation upon oral squamous cell carcinoma cells. Oral Diseases 2013 19 5 465 472 10.1111/odi.12025
124. Tabassum A., Bristow R. G., Venkateswaran V., Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing? Cancer Treatment Reviews 2010 36 3 230 234 2-s2.0-77951205496 10.1016/j.ctrv.2009.12. 008